The Thioredoxin System of Mammalian Cells and Its Modulators
Tóm tắt
Oxidative stress involves the increased production and accumulation of free radicals, peroxides, and other metabolites that are collectively termed reactive oxygen species (ROS), which are produced as by-products of aerobic respiration. ROS play a significant role in cell homeostasis through redox signaling and are capable of eliciting damage to macromolecules. Multiple antioxidant defense systems have evolved to prevent dangerous ROS accumulation in the body, with the glutathione and thioredoxin/thioredoxin reductase (Trx/TrxR) systems being the most important. The Trx/TrxR system has been used as a target to treat cancer through the thiol–disulfide exchange reaction mechanism that results in the reduction of a wide range of target proteins and the generation of oxidized Trx. The TrxR maintains reduced Trx levels using NADPH as a co-substrate; therefore, the system efficiently maintains cell homeostasis. Being a master regulator of oxidation–reduction processes, the Trx-dependent system is associated with cell proliferation and survival. Herein, we review the structure and catalytic properties of the Trx/TrxR system, its role in cellular signaling in connection with other redox systems, and the factors that modulate the Trx system.
Từ khóa
Tài liệu tham khảo
Tretter, V., Hochreiter, B., Zach, M.L., Krenn, K., and Klein, K. (2022). Understanding Cellular Redox Homeostasis: A Challenge for Precision Medicine. Int. J. Mol. Sci., 23.
Ren, 2017, Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System, Antioxid. Redox Signal., 27, 989, 10.1089/ars.2016.6925
Hanschmann, 2013, Thioredoxins, Glutaredoxins, and Peroxiredoxins—Molecular Mechanisms and Health Significance: From Cofactors to Antioxidants to Redox Signaling, Antioxid. Redox Signal., 19, 1539, 10.1089/ars.2012.4599
Jastrzab, 2021, Thioredoxin-dependent system. Application of inhibitors, J. Enzyme Inhib. Med. Chem., 36, 362, 10.1080/14756366.2020.1867121
Patwardhan, 2022, Thioredoxin reductase: An emerging tarfet for radiosensitization of cancer, Transl. Oncol., 17, 101341, 10.1016/j.tranon.2022.101341
Balsera, 2019, Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress, Free Radic. Biol. Med., 140, 28, 10.1016/j.freeradbiomed.2019.03.003
Lu, 2014, The thioredoxin antioxidant system, Free Radic. Biol. Med., 66, 75, 10.1016/j.freeradbiomed.2013.07.036
Jia, 2019, The role of thioredoxin system in cancer: Strategy for cancer therapy, Cancer Chemother. Pharmacol., 84, 453, 10.1007/s00280-019-03869-4
Scalcon, 2018, Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors, Free Radic. Biol. Med., 127, 62, 10.1016/j.freeradbiomed.2018.03.043
Branco, 2020, Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System, Curr. Med. Chem., 27, 1878, 10.2174/0929867326666190201113004
Kang, 2014, Thioredoxin and hematologic malignancies, Adv. Cancer Res., 122, 245, 10.1016/B978-0-12-420117-0.00007-4
Nordberg, 2001, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system, Free Radic. Biol. Med., 31, 1287, 10.1016/S0891-5849(01)00724-9
González, D., Álamos, P., Rivero, M., Orellana, O., Norambuena, J., Chávez, R., and Levicán, G. (2020). Deciphering the Role of Multiple Thioredoxin Fold Proteins of Leptospirillum sp. in Oxidative Stress Tolerance. Int. J. Mol. Sci., 21.
Yodoi, J., Matsuo, Y., Tian, H., Masutani, H., and Inamoto, T. (2017). Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care. Nutrients, 9.
Marchand, C.H., Fermani, S., Rossi, J., Gurrieri, L., Tedesco, D., Henri, J., Sparla, F., Trost, P., Lemaire, S.D., and Zaffagnini, M. (2019). Structural and Biochemical Insights into the Reactivity of Thioredoxin h1 from Chlamydomonas reinhardtii. Antioxidants, 8.
Noguera, 2017, Structural variability of E. coli thioredoxin captured in the crystal structures of single-point mutants, Sci. Rep., 7, 42343, 10.1038/srep42343
Buchko, 2018, Solution NMR structures of oxidized and reduced Ehrlichia chaffeensis thioredoxin: NMR-invisible structure owing to backbone dynamics, Acta Crystallogr. Sect. F Struct. Biol. Commun., 74, 46, 10.1107/S2053230X1701799X
Lee, 2013, Thioredoxin and Thioredoxin Target Proteins: From Molecular Mechanisms to Functional Significance, Antioxid. Redox Signal., 18, 1165, 10.1089/ars.2011.4322
Awan, 2022, The Functions of Thioredoxin 1 in Neurodegeneration, Antioxid. Redox Signal., 36, 1023, 10.1089/ars.2021.0186
Collet, 2010, Structure, Function, and Mechanism of Thioredoxin Proteins, Antioxid. Redox Signal., 13, 1205, 10.1089/ars.2010.3114
Monteiro, 2017, Thioredoxin promotes survival signaling events under nitrosative/oxidative stress associated with cancer development, Biomed. J., 40, 189, 10.1016/j.bj.2017.06.002
Mougiakakos, 2011, Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress, Blood, 117, 857, 10.1182/blood-2010-09-307041
Chen, 2019, A Unique SUMO-Interacting Motif of Trx2 Is Critical for Its Mitochondrial Presequence Processing and Anti-oxidant Activity, Front. Physiol., 10, 1089, 10.3389/fphys.2019.01089
Ouyang, 2018, Modulation of thiol-dependent redox system by metal ions via thioredoxin and glutaredoxin systems, Metallomics, 10, 218, 10.1039/C7MT00327G
Lillig, 2007, Thioredoxin and Related Molecules–From Biology to Health and Disease, Antioxid. Redox Signal., 9, 25, 10.1089/ars.2007.9.25
Foloppe, 2001, Structure, dynamics and electrostatics of the active site of glutaredoxin 3 from Escherichia coli: Comparison with functionally related proteins, J. Mol. Biol., 310, 449, 10.1006/jmbi.2001.4767
Kouwen, 2008, Thioredoxin Active-Site Mutants Form Mixed Disulfide Dimers That Resemble Enzyme–Substrate Reaction Intermediates, J. Mol. Biol., 379, 520, 10.1016/j.jmb.2008.03.077
Du, 2013, Thioredoxin 1 Is Inactivated Due to Oxidation Induced by Peroxiredoxin under Oxidative Stress and Reactivated by the Glutaredoxin System, J. Biol. Chem., 288, 32241, 10.1074/jbc.M113.495150
Watson, 2003, Redox Potential of Human Thioredoxin 1 and Identification of a Second Dithiol/Disulfide Motif, J. Biol. Chem., 278, 33408, 10.1074/jbc.M211107200
Haendeler, 2002, Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69, Nat. Cell Biol., 4, 743, 10.1038/ncb851
Kern, 2003, Chaperone properties of Escherichia coli thioredoxin and thioredoxin reductase, Biochem. J., 371, 965, 10.1042/bj20030093
Carballeda, 2012, Chaperone-like properties of tobacco plastid thioredoxins f and m, J. Exp. Bot., 63, 365, 10.1093/jxb/err282
Du, 2015, A Cytosolic Thioredoxin Acts as a Molecular Chaperone for Peroxisome Matrix Proteins as Well as Antioxidant in Peroxisome, Mol. Cells, 38, 187, 10.14348/molcells.2015.2255
Currier, R.B., Ulrich, K., Leroux, A.E., Dirdjaja, N., Deambrosi, M., Bonilla, M., Ahmed, Y.L., Adrian, L., Antelmann, H., and Jakob, U. (2019). An essential thioredoxin-type protein of Trypanosoma brucei acts as redox-regulated mitochondrial chaperone. PLoS Pathog., 15.
Kim, M.-K., Zhao, L., Jeong, S., Zhang, J., Jung, J.-H., Seo, H.S., Choi, J., and Lim, S. (2021). Structural and Biochemical Characterization of Thioredoxin-2 from Deinococcus radiodurans. Antioxidants, 10.
Zou, 2021, Thioredoxin reductase as a pharmacological target, Pharmacol. Res., 174, 105854, 10.1016/j.phrs.2021.105854
Sandalova, 2001, Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme, Proc. Natl. Acad. Sci. USA, 98, 9533, 10.1073/pnas.171178698
Gasdaska, 1995, Cloning and sequencing of a human thioredoxin reductase, FEBS Lett., 373, 5, 10.1016/0014-5793(95)01003-W
Waksman, 1994, Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis, J. Mol. Biol., 236, 800, 10.1006/jmbi.1994.1190
Zhang, 2021, Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells, Front. Mol. Biosci., 8, 710676, 10.3389/fmolb.2021.710676
Mahmood, 2013, The Thioredoxin System as a Therapeutic Target in Human Health and Disease, Antioxid. Redox Signal., 19, 1266, 10.1089/ars.2012.4757
2009, Focus on mammalian thioredoxin reductases—Important selenoproteins with versatile functions, Biochim. Biophys. Acta BBA-Gen. Subj., 1790, 495, 10.1016/j.bbagen.2009.01.014
Joardar, 2020, Thiol antioxidant thioredoxin reductase: A prospective biochemical crossroads between anticancer and antiparasitic treatments of the modern era, Int. J. Biol. Macromol., 165, 249, 10.1016/j.ijbiomac.2020.09.096
Damdimopoulos, 1999, Human mitochondrial thioredoxin reductase. cDNA cloning, expression and genomic organization, Eur. J. Biochem., 261, 405, 10.1046/j.1432-1327.1999.00286.x
Liu, 2016, Truncated Escherichia coli thioredoxin induces proliferation of human blood mononuclear cells and production of reactive oxygen species as well as proinflammatory cytokines: Truncated E. coli Thioredoxin Induces Proliferation of PBMCs, Cell Biochem. Funct., 34, 226, 10.1002/cbf.3180
Pekkari, 2004, Truncated Thioredoxin: Physiological Functions and Mechanism, Antioxid. Redox Signal., 6, 53, 10.1089/152308604771978345
Manabe, 2014, Redox proteins are constitutively secreted by skeletal muscle, J. Physiol. Sci., 64, 401, 10.1007/s12576-014-0334-7
2017, Cell Signaling with Extracellular Thioredoxin and Thioredoxin-Like Proteins: Insight into Their Mechanisms of Action, Oxid. Med. Cell. Longev., 2017, 8475125, 10.1155/2017/8475125
Mourenza, 2020, The extracellular thioredoxin Etrx3 is required for macrophage infection in Rhodococcus equi, Vet. Res., 51, 38, 10.1186/s13567-020-00763-3
Plugis, 2018, Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin, Proc. Natl. Acad. Sci. USA, 15, 8781, 10.1073/pnas.1805288115
Nakamura, 2006, Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer, Semin. Cancer Biol., 16, 444, 10.1016/j.semcancer.2006.09.001
Powis, 2001, Properties and Biological Activities of Thioredoxins, Annu. Rev. Pharmacol. Toxicol., 41, 261, 10.1146/annurev.pharmtox.41.1.261
Jin, 2011, Lipid Raft Redox Signaling: Molecular Mechanisms in Health and Disease, Antioxidants Redox Signal., 15, 1043, 10.1089/ars.2010.3619
Sorice, 2021, Targeting Lipid Rafts as a Strategy Against Coronavirus, Front. Cell Dev. Biol., 8, 618296, 10.3389/fcell.2020.618296
Kondo, 2007, Lipid Raft–Mediated Uptake of Cysteine-Modified Thioredoxin-1: Apoptosis Enhancement by Inhibiting the Endogenous Thioredoxin-1, Antioxid. Redox Signal., 9, 1439, 10.1089/ars.2007.1665
Meijles, 2020, Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension, Hypertension, 76, 1208, 10.1161/HYPERTENSIONAHA.119.14556
Psenakova, 2020, The redox-active site of thioredoxin is directly involved in apoptosis signal-regulating kinase 1 binding that is modulated by oxidative stress, FEBS J., 287, 1626, 10.1111/febs.15101
Nadeau, 2007, Disulfide Bond-mediated Multimerization of Ask1 and Its Reduction by Thioredoxin-1 Regulate H2O2-induced c-Jun NH2-terminal Kinase Activation and Apoptosis, Mol. Biol. Cell, 18, 3903, 10.1091/mbc.e07-05-0491
Shu, 2020, Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1/p38-MAPK signalling pathway, Redox Biol., 29, 101400, 10.1016/j.redox.2019.101400
Kekulandara, 2018, Redox-Inactive Peptide Disrupting Trx1–Ask1 Interaction for Selective Activation of Stress Signaling, Biochemistry, 57, 772, 10.1021/acs.biochem.7b01083
Zhang, 2004, Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner, Circ. Res., 94, 1483, 10.1161/01.RES.0000130525.37646.a7
Wei, 2021, Mechanisms of Trx2/ASK1-Mediated Mitochondrial Injury in Pemphigus Vulgaris, BioMed Res. Int., 2021, 1
Hu, 2018, The Function of Thioredoxin-Binding Protein-2 (TBP-2) in Different Diseases, Oxid. Med. Cell. Longev., 2018, 4582130, 10.1155/2018/4582130
Al-Kandari, N., Fadel, F., Al-Saleh, F., Khashab, F., and Al-Maghrebi, M. (2019). The Thioredoxin System is Regulated by the ASK-1/JNK/p38/Survivin Pathway During Germ Cell Apoptosis. Molecules, 24.
Nguyen, 2021, Caspases in the Developing Central Nervous System: Apoptosis and Beyond, Front. Cell Dev. Biol., 9, 702404, 10.3389/fcell.2021.702404
Mitchell, 2007, Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells, Proc. Natl. Acad. Sci. USA, 104, 11609, 10.1073/pnas.0704898104
Shelar, 2015, Thioredoxin-dependent regulation of AIF-mediated DNA damage, Free Radic. Biol. Med., 87, 125, 10.1016/j.freeradbiomed.2015.06.029
Shields, 2021, Beneficial and Detrimental Effects of Reactive Oxygen Species on Lifespan: A Comprehensive Review of Comparative and Experimental Studies, Front. Cell Dev. Biol., 9, 628157, 10.3389/fcell.2021.628157
Ghimire, 2017, Nitric oxide: What’s new to NO?, Am. J. Physiol.-Cell Physiol., 312, C254, 10.1152/ajpcell.00315.2016
Ogata, F.T., Batista, W.L., Sartori, A., Gesteira, T.F., Masutani, H., Arai, R.J., Yodoi, J., Stern, A., and Monteiro, H.P. (2013). Nitrosative/Oxidative Stress Conditions Regulate Thioredoxin-Interacting Protein (TXNIP) Expression and Thioredoxin-1 (TRX-1) Nuclear Localization. PLoS ONE, 8.
Harper, 2019, Auranofin, a thioredoxin reductase inhibitor, causes platelet death through calcium overload, Platelets, 30, 98, 10.1080/09537104.2017.1378809
Mohammadi, 2019, The thioredoxin system and cancer therapy: A review, Cancer Chemother. Pharmacol., 84, 925, 10.1007/s00280-019-03912-4
Zhang, 2017, Targeting the Thioredoxin System for Cancer Therapy, Trends Pharmacol. Sci., 38, 794, 10.1016/j.tips.2017.06.001
Zhang, 2019, Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug, Biochimie, 162, 46, 10.1016/j.biochi.2019.03.015
Schmidt, 2017, Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects, Chem.-Eur. J., 23, 1869, 10.1002/chem.201604512
Arambula, 2016, Targeting antioxidant pathways with ferrocenylated N-heterocyclic carbene supported gold(i) complexes in A549 lung cancer cells, Chem. Sci., 7, 1245, 10.1039/C5SC03519H
Branco, 2011, Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury, Toxicol. Appl. Pharmacol., 251, 95, 10.1016/j.taap.2010.12.005
Xiao, 2012, 3-Nitro-2 H -chromenes as a New Class of Inhibitors against Thioredoxin Reductase and Proliferation of Cancer Cells, Arch. Pharm., 345, 767, 10.1002/ardp.201200121
Andermark, 2013, Butyltin(IV) Benzoates: Inhibition of Thioredoxin Reductase, Tumor Cell Growth Inhibition, and Interactions with Proteins, ChemMedChem, 8, 256, 10.1002/cmdc.201200505
Oehninger, 2013, A Chemical-Biological Evaluation of Rhodium(I) N -Heterocyclic Carbene Complexes as Prospective Anticancer Drugs, Chem.-Eur. J., 19, 17871, 10.1002/chem.201302819
Yan, 2012, Antitumor Indolequinones Induced Apoptosis in Human Pancreatic Cancer Cells via Inhibition of Thioredoxin Reductase and Activation of Redox Signaling, Mol. Pharmacol., 81, 401, 10.1124/mol.111.076091
Cotugno, 2014, Powerful tumor cell growth-inhibiting activity of a synthetic derivative of atractyligenin: Involvement of PI3K/Akt pathway and thioredoxin system, Biochim. Biophys. Acta BBA-Gen. Subj., 1840, 1135, 10.1016/j.bbagen.2013.11.023
Duan, 2014, Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase, Free Radic. Biol. Med., 69, 15, 10.1016/j.freeradbiomed.2013.12.027
Amin, A.R.M.R., Haque, A., Rahman, M.A., Chen, Z.G., Khuri, F.R., and Shin, D.M. (2015). Curcumin Induces Apoptosis of Upper Aerodigestive Tract Cancer Cells by Targeting Multiple Pathways. PLoS ONE, 10.
2019, Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression-independent manner in HPV-positive human cervical cancer-derived cells, Mol. Med. Rep., 19, 2097
Sun, S., Zhang, Y., Xu, W., Zhang, Y., Yang, R., Guo, J., Guan, S., Ma, Q., Ma, K., and Xu, J. (2021). Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death. Antioxidants, 10.
He, 2012, Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy, Bioorg. Med. Chem., 20, 3816, 10.1016/j.bmc.2012.04.033
Liu, 2014, Dithiaarsanes Induce Oxidative Stress-Mediated Apoptosis in HL-60 Cells by Selectively Targeting Thioredoxin Reductase, J. Med. Chem., 57, 5203, 10.1021/jm500221p
Sun, 2012, Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: An effect controlled by the thioredoxin system, Breast Cancer Res., 14, R20, 10.1186/bcr3105
Gandin, 2015, Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents, Molecules, 20, 12732, 10.3390/molecules200712732
Saccoccia, 2012, On the mechanism and rate of gold incorporation into thiol-dependent flavoreductases, J. Inorg. Biochem., 108, 105, 10.1016/j.jinorgbio.2011.11.005
Jeong, 2017, Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species, Gen. Physiol. Biophys., 36, 117, 10.4149/gpb_2016043
Cheng, 2020, Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury, Biochem. Pharmacol., 175, 113873, 10.1016/j.bcp.2020.113873
Cebula, 2010, Noble metal targeting of thioredoxin reductase—covalent complexes with thioredoxin and thioredoxin-related protein of 14kDa triggered by cisplatin, Free Radic. Biol. Med., 49, 1765, 10.1016/j.freeradbiomed.2010.09.008
Rubbiani, 2014, Anticancer Profile of a Series of Gold(III) (2-phenyl)pyridine Complexes, ChemMedChem, 9, 2781, 10.1002/cmdc.201402446
Ojo, 2022, From wandering weeds to pharmacy: An insight into traditional uses, phytochemicals and pharmacology of genus Chromolaena (Asteraceae), J. Ethnopharmacol., 291, 115155, 10.1016/j.jep.2022.115155
Fang, 2005, Thioredoxin Reductase Is Irreversibly Modified by Curcumin, J. Biol. Chem., 280, 25284, 10.1074/jbc.M414645200
Srivastava, 2019, 2019. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells, Phytomedicine, 52, 117, 10.1016/j.phymed.2018.09.224
Lu, 2006, Inhibition of Mammalian Thioredoxin Reductase by Some Flavonoids: Implications for Myricetin and Quercetin Anticancer Activity, Cancer Res., 66, 4410, 10.1158/0008-5472.CAN-05-3310
Sun, 2017, The Natural Diterpenoid Isoforretin A Inhibits Thioredoxin-1 and Triggers Potent ROS-Mediated Antitumor Effects, Cancer Res., 77, 926, 10.1158/0008-5472.CAN-16-0987
Perin, 2016, Synthesis of Organochalcogen Compounds using Non-Conventional Reaction Media, ChemistrySelect, 1, 205, 10.1002/slct.201500031
Sudati, 2018, Diselenoamino acid derivatives as GPx mimics and as substrates of TrxR: in vitro and in silico studies, Org. Biomol. Chem., 16, 3777, 10.1039/C8OB00451J
Hirota, 2002, Thioredoxin Superfamily and Thioredoxin-Inducing Agents, Ann. N. Y. Acad. Sci., 957, 189, 10.1111/j.1749-6632.2002.tb02916.x
Li, 2018, Overexpression of Thioredoxin-1 Blocks Morphine-Induced Conditioned Place Preference Through Regulating the Interaction of γ-Aminobutyric Acid and Dopamine Systems, Front. Neurol., 9, 309, 10.3389/fneur.2018.00309
Carvalho, 2011, Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: Implications for treatment of mercury poisoning, FASEB J., 25, 370, 10.1096/fj.10-157594
Dharmaraja, 2017, Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria, J. Med. Chem., 60, 3221, 10.1021/acs.jmedchem.6b01243
Tonelli, 2018, Transcriptional Regulation by Nrf2, Antioxid. Redox Signal., 29, 1727, 10.1089/ars.2017.7342
Jaganjac, M., Milkovic, L., Borovic Sunjic, S., and Zarkovic, N. (2020). The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies. Antioxidants, 9.
Kim, 2010, Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt, Int. J. Biochem. Cell Biol., 42, 297, 10.1016/j.biocel.2009.11.009
Joo, 2016, AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550, Mol. Cell. Biol., 36, 1931, 10.1128/MCB.00118-16
Cebula, 2015, TrxR1 as a potent regulator of the Nrf2-Keap1 response system, Antioxidants Redox Signal., 23, 823, 10.1089/ars.2015.6378
Anestal, K., Prast-Nielsen, S., Cenas, N., and Arner, E.S. (2008). Cell death by SecTRAPs: Thioredoxin reductase as a prooxidant killer of cells. PLoS ONE, 3.
Matsuzawa, 2017, Thioredoxin and redox signaling: Roles of the thioredoxin system in control of cell fate, Arch. Biochem. Biophys., 617, 101, 10.1016/j.abb.2016.09.011
Lincoln, 2003, The thioredoxin-thioredoxin reductase system: Over-expression in human cancer, Anticancer Res., 23, 2425
Krasavin, 2022, The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance, Front. Mol. Biosci., 9, 883297, 10.3389/fmolb.2022.883297
Powis, 1998, Thioredoxin redox control of cell growth and death and the effects of inhibitors, Chem. Biol. Interact., 111–112, 23, 10.1016/S0009-2797(97)00148-8
Yamawaki, 2003, Thioredoxin: A Key Regulator of Cardiovascular Homeostasis, Circ. Res., 93, 1029, 10.1161/01.RES.0000102869.39150.23
Saad, 2018, Thioredoxin-1 augments wound healing and promote angiogenesis in a murine ischemic full-thickness wound model, Surgery, 164, 1077, 10.1016/j.surg.2018.05.045
Welsh, 2002, The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis, Cancer Res., 62, 5089
Du, 2012, Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose, J. Biol. Chem., 287, 38210, 10.1074/jbc.M112.392225
Benhar, 2016, Dual targeting of the thioredoxin and glutathione systems in cancer and HIV, J. Clin. Investig., 126, 1630, 10.1172/JCI85339
Avval, 2009, Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase, J. Biol. Chem., 284, 8233, 10.1074/jbc.M809338200
Sengupta, 2019, Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2–R1-dependent ribonucleotide reductase, J. Biol. Chem., 294, 12708, 10.1074/jbc.RA119.008752
Rhee, 2005, Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling, Free Radic. Biol. Med., 38, 1543, 10.1016/j.freeradbiomed.2005.02.026
Wu, M., Deng, C., Lo, T.H., Chan, K.Y., Li, X., and Wong, C.M. (2022). Peroxiredoxin, Senescence, and Cancer. Cells, 11.
Pannala, 2015, Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide, Free Radic. Biol. Med., 78, 42, 10.1016/j.freeradbiomed.2014.10.508